Chong Kun Dang Pharmaceutical
Clinical trials sponsored by Chong Kun Dang Pharmaceutical, explained in plain language.
-
New hope for advanced cancers: first human trial of CKD-512 begins
Disease control Recruiting nowThis study tests a new experimental drug called CKD-512, given alone or with another cancer drug (pembrolizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goal is to find a safe dose and check for side effects. About 60 pa…
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New combo pill aims to beat standard blood pressure treatment
Disease control Recruiting nowThis study tests a new pill (CKD-202A) that combines two blood pressure medicines (sacubitril and valsartan) against a standard pill (valsartan alone). About 324 adults with high blood pressure will take one of the two pills daily for several weeks. Researchers will measure if th…
Phase: PHASE3 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC